"Rote-Hand-Briefe" (equivalent to Dear Doctor Letters) and Information Letters from the year 2013
Here you will find Information Letters and so-called "Rote-Hand-Briefe" sent out by pharmaceutical companies informing healthcare experts about newly identified major drug-associated risks and measures to reduce them.
The information published here only applies to drugs which are in the BfArM's responsibility.
For "Rote-Hand-Briefe" and Information Letters published by the Paul-Ehrlich-Institute for vaccines and biomedical products please click here.
The documents listed below are available in German only.
Search results 1 to 20 from a total of 21 (2 pages).
| Title | Date | Download |
|---|---|---|
|
Rote-Hand-Brief on Gilenya® Active substance: fingolimod
|
2013.01.08 |  download (file size: 56 KB) |
|
Rote-Hand-Brief on Protelos® Active substance: strontium ranelate
|
2013.05.13 | download (file size: 301 KB) |
|
Rote-Hand-Brief on Pletal® Active substance: cilostazole |
2013.05.02 | download (file size: 3 MB) |
|
Rote-Hand-Brief on Tavor® pro injectione 2 mg Injektionslösung Active substance: lorazepam |
2013.05.02 | download (file size: 119 KB) |
|
Information Letter on Increlex® Active substance: mecasermin, recombinant human IGF-1 |
2013.04.30 | download (file size: 208 KB) |
|
Information Letter on Caelyx® Active substance: pegylated liposomal doxorubicin |
2013.04.23 | download (file size: 408 KB) |
|
Rote-Hand-Brief on INCIVO® Active substance: telaprevir |
2013.04.08 | download (file size: 351 KB) |
|
Rote-Hand-Brief on Thalidomide Celgene™ Active substance: thalidomide updated |
2013.04.08 | download (file size: 288 KB) |
|
Rote-Hand-Brief on Mimpara® Active substance: cinacalcet |
2013.03.26 | download (file size: 338 KB) |
|
Information Letter on NULOJIX® Active substance: belatacept
|
2013.03.26 | download (file size: 113 KB) |
|
Rote-Hand-Brief on Durogesic® SMAT Active substance: fentanyl |
2013.03.11 | download (file size: 392 KB) |
|
Rote-Hand-Brief on Fentanyl®-Janssen Active substance: fentanyl |
2013.03.11 | download (file size: 430 KB) |
|
Rote-Hand-Brief on Vistide® Active substance: cidofovir |
2013.02.28 | download (file size: 122 KB) |
|
Information Letter on NeuroBloc® Active substance: botulinum toxin type B |
2013.02.22 | download (file size: 848 KB) |
|
Rote-Hand-Brief on tolperisone-containing medicinal products Active substance: tolperisone |
2013.02.21 | download (file size: 155 KB) |
|
Information Letter on Optimark® Active substance: gadolinium |
2013.02.21 | download (file size: 73 KB) |
|
Rote-Hand-Brief on Xagrid® Active substance: anagrelide hydrochloride |
2013.02.06 | download (file size: 466 KB) |
|
Rote-Hand-Brief on Tredaptive® Active substance: nicotinic acid, laropiprant |
2013.01.22 | download (file size: 584 KB) |
|
Rote-Hand-Brief on Pradaxa® Active substance: dabigatran etexilate |
2013.01.08 | download (file size: 337 KB) |
|
Rote-Hand-Brief on Angiox® Active substance: bivalirudine |
2013.01.08 | download (file size: 235 KB) |